Orphazyme completes sale of substantially all of its assets and business activities to KemPharm
yahoo.com
finance
2022-05-31 16:57:00

ORPHAZYME A/S

Orphazyme A/S

Company announcement

No. 29/2022

Inside information

www.orphazyme.com

Company Registration No. 32266355









Copenhagen, Denmark, May 31, 2022 â€“ With reference to company announcement no. 24/2022 dated May 15, 2022, regarding the signing of an agreement to sell substantially all of the Orphazyme's assets and business activities to KemPharm Denmark A/S, a wholly owned subsidiary of KemPharm Inc. (KMPH: NASDAQ, NY), ('KemPharm'), and company announcement no. 28/2022 dated May 30, 2022, regarding the approval of the restructuring proposal, Orphazyme A/S (ORPH) ('Orphazyme' or the 'Company'), today announces that it has completed the sale of substantially all of its assets and business activities for a cash consideration of USD 12.
